{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:25:05Z","timestamp":1781645105353,"version":"3.54.5"},"reference-count":67,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.iac.2024.03.003","type":"journal-article","created":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T04:10:21Z","timestamp":1716005421000},"page":"439-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Chronic Inducible Urticaria"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-8572-3399","authenticated-orcid":false,"given":"Dorothea","family":"Ritzel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9955-385X","authenticated-orcid":false,"given":"Sabine","family":"Altrichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.iac.2024.03.003_bib1","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1111\/all.13878","article-title":"Diagnosis and treatment of chronic inducible urticaria","volume":"74","author":"Maurer","year":"2019","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.iac.2024.03.003_bib2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3904\/kjim.2012.27.4.478","article-title":"A\u00a0Case of Combined Cholinergic and Cold Urticaria","volume":"27","author":"Cheon","year":"2012","journal-title":"Korean J Intern Med"},{"issue":"1","key":"10.1016\/j.iac.2024.03.003_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0091-6749(79)90159-3","article-title":"Evaluation of a patient with cold and cholinergic urticaria","volume":"63","author":"Sigler","year":"1979","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2024.03.003_bib4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/pai.13324","article-title":"Chronic inducible urticaria subtypes in children: Clinical features and prognosis","volume":"32","author":"Bal","year":"2021","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"10.1016\/j.iac.2024.03.003_bib5","doi-asserted-by":"crossref","first-page":"e313","DOI":"10.1542\/peds.113.4.e313","article-title":"Clinical Features and Anaphylaxis in Children With Cold Urticaria","volume":"113","author":"Alangari","year":"2004","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.iac.2024.03.003_bib6","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/all.12884","article-title":"The definition, diagnostic testing, and management of chronic inducible urticarias \u2013 The EAACI\/GA2LEN\/EDF\/UNEV consensus recommendations 2016 update and revision","volume":"71","author":"Magerl","year":"2016","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2024.03.003_bib7","first-page":"73","article-title":"Physical Urticarias and Cholinergic Urticaria","volume":"34","author":"Abajian","year":"2014","journal-title":"Immunol Allergy Clin"},{"issue":"3","key":"10.1016\/j.iac.2024.03.003_bib8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1067\/mjd.2001.116217","article-title":"Natural course of physical and chronic urticaria and angioedema in 220 patients","volume":"45","author":"Kozel","year":"2001","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2024.03.003_bib9","doi-asserted-by":"crossref","DOI":"10.15570\/actaapa.2020.29","article-title":"Chronic inducible urticaria: classification and prominent features of physical and non-physical types","volume":"29","author":"Pozderac","year":"2020","journal-title":"Acta Dermatovenerol Alpina Pannonica Adriatica"},{"issue":"4","key":"10.1016\/j.iac.2024.03.003_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/ced.12547","article-title":"Validation of a simplified provocation instrument for diagnosis and threshold testing of symptomatic dermographism","volume":"40","author":"Schoepke","year":"2015","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2024.03.003_bib11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1046\/j.0022-202x.2001.00030.x","article-title":"Delayed Pressure Urticaria","volume":"6","author":"Kobza-Black","year":"2001","journal-title":"J\u00a0Invest Dermatol Symp Proc"},{"issue":"4","key":"10.1016\/j.iac.2024.03.003_bib12","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.jaip.2018.03.007","article-title":"How to Approach Chronic Inducible Urticaria","volume":"6","author":"Maurer","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2024.03.003_bib13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jaci.2017.01.043","article-title":"Omalizumab is effective in cold urticaria\u2014results of a randomized placebo-controlled trial","volume":"140","author":"Metz","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.iac.2024.03.003_bib14","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0091-6749(81)90209-8","article-title":"Identification of a new physically induced urticaria: cold-induced cholinergic urticaria","volume":"68","author":"Kaplan","year":"1981","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2024.03.003_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0091-6749(84)90354-3","article-title":"Unusual cold-induced disorders: cold-dependent dermatographism and systemic cold urticaria","volume":"73","author":"Kaplan","year":"1984","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2024.03.003_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2230.2007.02376.x","article-title":"Acquired cold urticaria: clinical picture and update on diagnosis and treatment","volume":"32","author":"Siebenhaar","year":"2007","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2024.03.003_bib17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/all.14674","article-title":"Cold urticaria \u2013 What we know and what we do not know","volume":"76","author":"Maltseva","year":"2021","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2024.03.003_bib18","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.iac.2024.03.003_bib19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s001050050461","article-title":"Epidemiologie und Klinik der K\u00e4lteurtikaria","volume":"47","author":"M\u00f6ller","year":"1996","journal-title":"Hautarzt"},{"issue":"4","key":"10.1016\/j.iac.2024.03.003_bib20","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0091-6749(77)90050-1","article-title":"Delayed cold-induced urticaria: a dominantly inherited disorder","volume":"59","author":"Soter","year":"1977","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2024.03.003_bib21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41467-019-13984-8","article-title":"Cold-induced urticarial autoinflammatory syndrome related to factor XII activation","volume":"11","author":"Scheffel","year":"2020","journal-title":"Nat Commun"},{"issue":"3, Part 1","key":"10.1016\/j.iac.2024.03.003_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0091-6749(86)90027-8","article-title":"Clinical characteristics of cold-induced systemic reactions in acquired cold urticaria syndromes: Recommendations for prevention of this complication and a proposal for a diagnostic classification of cold urticaria","volume":"78","author":"Wanderer","year":"1986","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2024.03.003_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s13052-018-0578-6","article-title":"Anaphylaxis in atypical cold urticaria: case report and review of literature","volume":"44","author":"Benelli","year":"2018","journal-title":"Ital J Pediatr"},{"issue":"1","key":"10.1016\/j.iac.2024.03.003_bib24","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40257-022-00728-6","article-title":"Cholinergic Urticaria: Subtype Classification and Clinical Approach","volume":"24","author":"Fukunaga","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2024.03.003_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jdermsci.2014.04.007","article-title":"Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria","volume":"75","author":"Altrichter","year":"2014","journal-title":"J\u00a0Dermatol Sci"},{"key":"10.1016\/j.iac.2024.03.003_bib26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/CCID.S343462","article-title":"Cholinergic Urticaria, an Effective and Safe \u201cOff Label\u201d Use of Dupilumab: A Case Report with Literature Review","volume":"15","author":"Sirufo","year":"2022","journal-title":"Clin Cosmet Invest Dermatol"},{"issue":"5","key":"10.1016\/j.iac.2024.03.003_bib27","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2230.2011.04015.x","article-title":"A\u00a0case of cholinergic urticaria associated with acquired generalized hypohidrosis and reduced acetylcholine receptors: cause and effect?","volume":"36","author":"Nakamizo","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"10.1016\/j.iac.2024.03.003_bib29","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/jdv.12739","article-title":"An improved Peltier effect-based instrument for critical temperature threshold measurement in cold- and heat-induced urticaria","volume":"29","author":"Magerl","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.iac.2024.03.003_bib30","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/exd.14493","article-title":"Pathogenesis of solar urticaria: Classic perspectives and emerging concepts","volume":"31","author":"McSweeney","year":"2022","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.iac.2024.03.003_bib31","series-title":"StatPearls","article-title":"Solar Urticaria","author":"Harris","year":"2023"},{"issue":"6","key":"10.1016\/j.iac.2024.03.003_bib32","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0091-6749(76)90012-9","article-title":"Hereditary vibratory angioedema: confirmation of histamine release in a type of physical hypersensitivity","volume":"57","author":"Metzger","year":"1976","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.iac.2024.03.003_bib33","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1016\/j.jid.2020.03.936","article-title":"Critical Signaling Events in the Mechanoactivation of Human Mast Cells through p.C492Y-ADGRE2","volume":"140","author":"Naranjo","year":"2020","journal-title":"J\u00a0Invest Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2024.03.003_bib34","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.jaci.2018.10.049","article-title":"Ordinary vibratory angioedema is not generally associated with ADGRE2 mutation","volume":"143","author":"Zhao","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2024.03.003_bib35","first-page":"217","article-title":"Aquagenic urticaria with extracutaneous manifestations","volume":"26","author":"Baptist","year":"2005","journal-title":"Allergy Asthma Proc"},{"issue":"1","key":"10.1016\/j.iac.2024.03.003_bib36","first-page":"1","article-title":"Aquagenic urticaria in twins","volume":"6","author":"Kai","year":"2013","journal-title":"World Allergy Organization Journal"},{"issue":"3","key":"10.1016\/j.iac.2024.03.003_bib37","first-page":"467","article-title":"Contact Urticaria","volume":"41","author":"Gimenez-Arnau","year":"2021","journal-title":"Immunol Allergy Clin"},{"issue":"4","key":"10.1016\/j.iac.2024.03.003_bib38","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/ced.12107","article-title":"A\u00a0novel, simple, validated and reproducible instrument for assessing provocation threshold levels in patients with symptomatic dermographism","volume":"38","author":"Mlynek","year":"2013","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.iac.2024.03.003_bib39","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.jaci.2016.05.026","article-title":"Antihistamine updosing reduces disease activity in patients with difficult-to-treat cholinergic urticaria","volume":"138","author":"Koch","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.iac.2024.03.003_bib40","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1111\/all.15310","article-title":"Development of the Cold Urticaria Activity Score","volume":"77","author":"Ahsan","year":"2022","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.iac.2024.03.003_bib41","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1111\/all.12900","article-title":"The Angioedema Quality of Life Questionnaire (AE-QoL) - assessment of sensitivity to change and minimal clinically important difference","volume":"71","author":"Weller","year":"2016","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2024.03.003_bib42","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/bjd.19561","article-title":"The global burden of chronic urticaria for the patient and society","volume":"184","author":"Gon\u00e7alo","year":"2021","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.iac.2024.03.003_bib43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.iac.2024.03.003_bib44","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/cea.13102","article-title":"Development and validation of the Cholinergic Urticaria Quality-of-Life Questionnaire (CholU-QoL)","volume":"48","author":"Ruft","year":"2018","journal-title":"Clin Exp Allergy"},{"issue":"7","key":"10.1016\/j.iac.2024.03.003_bib45","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA2LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"issue":"8149","key":"10.1016\/j.iac.2024.03.003_bib46","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0140-6736(79)92664-3","article-title":"Cold urticaria treated by induction of tolerance","volume":"2","author":"Black","year":"1979","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.iac.2024.03.003_bib47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2133.1975.tb03057.x","article-title":"Localized heat urticaria treated by inducing tolerance to heat","volume":"92","author":"Leigh","year":"1975","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.iac.2024.03.003_bib48","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1001\/archderm.1977.01640090070008","article-title":"Solar urticaria treatment by inducing tolerance to artificial radiation and natural light","volume":"113","author":"Ramsay","year":"1977","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2024.03.003_bib49","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1067\/mjd.2000.104517","article-title":"UVA rush hardening for the treatment of solar urticaria","volume":"42","author":"Beissert","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.iac.2024.03.003_bib50","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000336572","article-title":"Cold Urticaria Patients Exhibit Normal Skin Levels of Functional Mast Cells and Histamine after Tolerance Induction","volume":"224","author":"Kring Tannert","year":"2012","journal-title":"Dermatology"},{"issue":"5","key":"10.1016\/j.iac.2024.03.003_bib51","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.jaci.2018.01.031","article-title":"Chronic inducible urticaria: A systematic review of treatment options","volume":"141","author":"Dressler","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2024.03.003_bib52","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.anai.2015.10.009","article-title":"Successful treatment of occupational delayed pressure urticaria and angioedema with omalizumab","volume":"116","author":"Geller","year":"2016","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.iac.2024.03.003_bib53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.aller.2012.11.001","article-title":"Successful treatment of severe delayed pressure angio-oedema with omalizumab","volume":"42","author":"Rodr\u00edguez-Rodr\u00edguez","year":"2014","journal-title":"Allergol Immunopathol"},{"issue":"6","key":"10.1016\/j.iac.2024.03.003_bib54","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/pai.12413","article-title":"Treatment with omalizumab in a 16-year-old Caucasian girl with refractory solar urticaria","volume":"26","author":"Arasi","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"issue":"4","key":"10.1016\/j.iac.2024.03.003_bib55","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/jdv.13001","article-title":"Three cases of solar urticaria successfully treated with omalizumab","volume":"30","author":"Baliu-Piqu\u00e9","year":"2016","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.iac.2024.03.003_bib56","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1398-9995.2007.01591.x","article-title":"Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy","volume":"63","author":"Metz","year":"2008","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.iac.2024.03.003_bib57","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1398-9995.2010.02409.x","article-title":"Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy","volume":"65","author":"Krause","year":"2010","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2024.03.003_bib58","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2017.01.042","article-title":"Omalizumab is effective in symptomatic dermographism-results of a randomized placebo-controlled trial","volume":"140","author":"Maurer","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2024.03.003_bib59","first-page":"519","article-title":"Omalizumab treatment in 2 cases of refractory heat urticaria","volume":"23","author":"Carballada","year":"2013","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2024.03.003_bib60","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.anai.2019.08.014","article-title":"New treatments for chronic urticaria","volume":"124","author":"Kolkhir","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.iac.2024.03.003_bib61","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1111\/jdv.14594","article-title":"Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticaria","volume":"32","author":"Maurer","year":"2018","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1016\/j.iac.2024.03.003_bib62","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1111\/jdv.15720","article-title":"Benefit of benralizumab treatment in a patient with chronic symptomatic dermographism","volume":"33","author":"Bergmann","year":"2019","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"5","key":"10.1016\/j.iac.2024.03.003_bib63","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.jaci.2021.12.772","article-title":"An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria","volume":"149","author":"Altrichter","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2024.03.003_bib64","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/all.15585","article-title":"Anti-KIT antibody, barzolvolimab, reduces skin mast cells and disease activity in chronic inducible urticaria","volume":"78","author":"Terhorst-Molawi","year":"2023","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.iac.2024.03.003_bib65","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1111\/all.15261","article-title":"Bruton\u2019s tyrosine kinase inhibition\u2014An emerging therapeutic strategy in immune mediated dermatological conditions","volume":"77","author":"Mendes Bastos","year":"2022","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2024.03.003_bib66","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.jaci.2022.08.027","article-title":"Remibrutinib, a novel BTK inhibitor, demonstrates promising efficacy and safety in chronic spontaneous urticaria","volume":"150","author":"Maurer","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2024.03.003_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1033794","article-title":"Inhibition of MRGPRX2 but not Fc\u03b5RI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist","volume":"13","author":"Bawazir","year":"2022","journal-title":"Front Immunol"},{"issue":"7887","key":"10.1016\/j.iac.2024.03.003_bib68","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41586-021-04126-6","article-title":"STRUCTURE, FUNCTION AND PHARMACOLOGY OF HUMAN ITCH GPCRs","volume":"600","author":"Cao","year":"2021","journal-title":"Nature"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856124000250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856124000250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T09:38:47Z","timestamp":1732009127000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856124000250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":67,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S0889856124000250"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2024.03.003","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Inducible Urticaria","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2024.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}